ClinicalTrials.gg
Sign In

Adrenal Gland Neoplasms clinical trials

The registry lists 62 studies for Adrenal Gland Neoplasms across more than 10 countries. 19 are recruiting or about to start. 22 of them are mainly about Adrenal Gland Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12. Counting its 4 narrower conditions too, such as Adrenocortical Carcinoma: 202 studies, 59 open.

Get an email when these change. Save the Adrenal Gland Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
23
Recruiting
16
Terminated
9
Active, not recruiting
5
Status unknown
5
Enrolling by invitation
2

Phase

Phase 2
12
Phase 1
9
Phase 3
4
Early Phase 1
2
Phase 4
2

Where

United States
20
Germany
8
China
5
Italy
4
France
4
Spain
3

Who runs them

National Cancer Institute (NCI) (5) · University of Wuerzburg (4) · The Affiliated Hospital of Qingdao University (3) · Instituto do Cancer do Estado de São Paulo (2) · Jonsson Comprehensive Cancer Center (2) · University of Roma La Sapienza (2) · Wuerzburg University Hospital (2) · M.D. Anderson Cancer Center (2)

What is being tested here

Drugs under test in Adrenal Gland Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Immunocytokine NHS-IL12101
Olaparib101
Lutetium Lu 177 dotatate101
Apatinib101
Mitotane101
FAPI-46 GA-68001
FAPI-46001
Nivolumab001
Cabozantinib001
Gefitinib001

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 1 open

Coming up

0phase 3 studies under way
4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Who these studies take

Of the 16 Adrenal Gland Neoplasms studies recruiting now, 10 (63%) set no upper age limit and 2 (13%) stop at 75 or younger. 6 (38%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (13%) take healthy volunteers.

Recruiting studies that take each age, of 16
AgeWomenMen
106 (38%)6 (38%)
1815 (94%)15 (94%)
3016 (100%)16 (100%)
4016 (100%)16 (100%)
5016 (100%)16 (100%)
6516 (100%)16 (100%)
7514 (88%)14 (88%)
8512 (75%)12 (75%)

Across all 62 studies, recruiting or not: 8% stop at 75 or younger and 3% at 65; 21% take children; 0% are for women only and 0% for men only; 6% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 62. Browse all 62 → or search them.